Get the Stockscreener App
17.10
4.97%
0.81
Mediwound Ltd stock is traded at $17.10, with a volume of 138.25K.
It is up +4.97% in the last 24 hours and down -10.42% over the past month.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
See More
Previous Close:
$16.29
Open:
$16.33
24h Volume:
138.25K
Relative Volume:
1.80
Market Cap:
$179.30M
Revenue:
$19.85M
Net Income/Loss:
$-12.75M
P/E Ratio:
-12.39
EPS:
-1.38
Net Cash Flow:
$-21.94M
1W Performance:
+13.62%
1M Performance:
-10.42%
6M Performance:
-5.58%
1Y Performance:
-1.95%
1-Day Range:
$16.33
$17.51
1-Week Range:
$15.00
$17.51
52-Week Range:
$12.78
$24.00
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
17.10 | 179.30M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-28-25 | Initiated | Craig Hallum | Buy |
| Jul-16-24 | Reiterated | Maxim Group | Buy |
| Dec-22-22 | Initiated | Maxim Group | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Sep-23-20 | Initiated | BTIG Research | Buy |
| Nov-28-16 | Initiated | Aegis Capital | Buy |
| Aug-17-16 | Initiated | Wells Fargo | Outperform |
| Apr-16-14 | Initiated | Oppenheimer | Outperform |
View All
Mediwound Ltd Stock (MDWD) Latest News
What You Can Learn From MediWound Ltd.'s (NASDAQ:MDWD) P/S - simplywall.st
Those who invested in MediWound (NASDAQ:MDWD) five years ago are up 30% - Yahoo Finance
MediWound schedules annual shareholder meeting for May 15 By Investing.com - Investing.com Canada
MediWound schedules annual shareholder meeting for May 15 - Investing.com Australia
MediWound Announces 2025 Annual General Meeting and Key Agenda Items - TipRanks
Trading (MDWD) With Integrated Risk Controls - news.stocktradersdaily.com
HC Wainwright Has Bearish Estimate for MediWound Q1 Earnings - Defense World
StockNews.com Upgrades MediWound (NASDAQ:MDWD) to “Sell” - Defense World
HC Wainwright Reaffirms Buy Rating for MediWound (NASDAQ:MDWD) - Defense World
HC Wainwright Comments on MediWound FY2029 Earnings - Defense World
When (MDWD) Moves Investors should Listen - news.stocktradersdaily.com
MediWound Ltd (MDWD) Q4 2024 Earnings Report Preview: What To Lo - GuruFocus.com
MediWound Full Year 2024 Earnings: EPS Beats Expectations - simplywall.st
Loss-Making MediWound Ltd. (NASDAQ:MDWD) Expected To Breakeven In The Medium-Term - Yahoo
MediWound Ltd (MDWD) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Losses - Yahoo Finance
MediWound Ltd (MDWD) Q4 2024 Earnings Call Highlights: Revenue G - GuruFocus
MediWound Ltd (MDWD) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Losses By GuruFocus - Investing.com Canada
MediWound Reports 2024 Financials and Strategic Advances - TipRanks
MediWound Files for $125 Million Mixed Shelf -March 19, 2025 at 04:55 pm EDT - Marketscreener.com
Mediwound files for mixed shelf offering of up to $125 mln -March 19, 2025 at 04:16 pm EDT - Marketscreener.com
Earnings call transcript: MediWound Q4 2024 beats EPS expectations By Investing.com - Investing.com Australia
MediWound: Q4 Earnings Snapshot - mySA
Earnings call transcript: MediWound Q4 2024 beats EPS expectations - Investing.com India
Mediwound Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
MediWound shares rise as Q4 loss is narrower than expected By Investing.com - Investing.com South Africa
MediWound shares rise as Q4 loss is narrower than expected - Investing.com India
Mediwound earnings beat by $0.20, revenue topped estimates - Investing.com India
MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Top Premarket Gainers -March 19, 2025 at 07:48 am EDT - Marketscreener.com
MediWound Reports 2024 Financial Results and Strategic Advances - TipRanks
MediWound: Q4 Earnings Snapshot -March 19, 2025 at 07:18 am EDT - Marketscreener.com
MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire
MEDIWOUND Earnings Preview: Recent $MDWD Insider Trading, Hedge Fund Activity, and More - Nasdaq
MediWound (NASDAQ:MDWD) shareholder returns have been respectable, earning 53% in 5 years - Simply Wall St
MediWound (MDWD) Projected to Post Earnings on Wednesday - Defense World
MediWound Ltd. (NASDAQ:MDWD) Shares Acquired by Rhumbline Advisers - Defense World
Pollard Banknote Reports 4th Quarter and Annual Financial Results - The Globe and Mail
MediWound Ltd. to Host Earnings Call - ACCESS Newswire
MediWound at TD Cowen Conference: Strategic Insights on Growth By Investing.com - Investing.com Australia
MediWound at TD Cowen Conference: Strategic Insights on Growth - Investing.com India
MediWound to Report Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
When Will MediWound Reveal Its 2024 Financial Performance? Key Date Announced - StockTitan
MediWound (NASDAQ:MDWD) Research Coverage Started at Craig Hallum - Defense World
MediWound (NASDAQ:MDWD) Now Covered by Analysts at Craig Hallum - MarketBeat
Mediwound Ltd Stock (MDWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):